These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 6382514

  • 1. Role of prostacyclin as a natural deterrent to hematogenous tumor metastasis.
    Honn KV, Menter DG, Onoda JM, Taylor JD, Sloane BF.
    Symp Fundam Cancer Res; 1983; 36():361-88. PubMed ID: 6382514
    [No Abstract] [Full Text] [Related]

  • 2. Prostacyclin, thromboxanes, and hematogenous metastasis.
    Honn KV, Sloane BF.
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():313-8. PubMed ID: 6221609
    [No Abstract] [Full Text] [Related]

  • 3. Possible strategies for antimetastastic therapy.
    Honn KV, Onoda JM, Menter DG, Cavanaugh PG, Taylor JD, Crissman JD, Ryan RE, Sloane BF.
    Prog Clin Biol Res; 1986; 212():217-49. PubMed ID: 3520578
    [No Abstract] [Full Text] [Related]

  • 4. [Role of prostaglandins, thromboxanes and prostacyclin in regulating the thrombocyte aggregation process and liberation reaction normally and in pathology].
    Baluda VP, Sushkevich GN, Lukoianova TI.
    Patol Fiziol Eksp Ter; 1980; (4):80-5. PubMed ID: 6251418
    [No Abstract] [Full Text] [Related]

  • 5. Prostacyclin and thromboxanes. Implications for their role in tumor cell metastasis.
    Honn KV, Busse WD, Sloane BF.
    Biochem Pharmacol; 1983 Jan 01; 32(1):1-11. PubMed ID: 6338880
    [No Abstract] [Full Text] [Related]

  • 6. Biological properties of prostacyclin-thromboxane system.
    Blaskó G.
    Ther Hung; 1984 Jan 01; 32(2):45-51. PubMed ID: 6443751
    [No Abstract] [Full Text] [Related]

  • 7. Thromboxane and prostacyclin: implications for function and disease of the vasculature.
    McGiff JC.
    Adv Intern Med; 1980 Jan 01; 25():199-216. PubMed ID: 6987841
    [No Abstract] [Full Text] [Related]

  • 8. Platelet cancer cell interaction in metastasis formation. Platelet aggregation inhibitors: a possible approach to metastasis prevention.
    Gastpar H, Ambrus JL, Ambrus CM.
    Prog Clin Biol Res; 1982 Jan 01; 89():63-82. PubMed ID: 7111310
    [Abstract] [Full Text] [Related]

  • 9. [Cancer blood-borne metastasis and platelets].
    Tanaka K, Fukumoto S.
    Gan To Kagaku Ryoho; 1984 Dec 01; 11(12 Pt 1):2453-9. PubMed ID: 6391385
    [Abstract] [Full Text] [Related]

  • 10. [Mechanism of action of antiplatelet medication].
    Navarro JL, Frade FJ, Alava I, Obispo T, Trejo R, Jiménez C, Cesar J.
    Sangre (Barc); 1984 Dec 01; 29(4-C):817-32. PubMed ID: 6096974
    [No Abstract] [Full Text] [Related]

  • 11. Humoral heartache -- do platelets have a role?
    Handin RI, Alexander RW.
    N Engl J Med; 1981 Apr 23; 304(17):1035-6. PubMed ID: 7010170
    [No Abstract] [Full Text] [Related]

  • 12. Sequential histamine inhalations cause increased bronchial histamine reactivity in guinea pigs: role of platelets, thromboxanes and prostacyclin.
    Dorsch W, Hintschich C, Neuhauser J, Weber J.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep 23; 327(2):148-55. PubMed ID: 6387510
    [Abstract] [Full Text] [Related]

  • 13. The role of prostacyclin and thromboxane A2 in the regulation of platelet behaviour.
    Moncada S.
    Mater Med Pol; 1980 Sep 23; 12(3):207-12. PubMed ID: 7019591
    [No Abstract] [Full Text] [Related]

  • 14. Prostacyclin/thromboxane-mediated mechanisms in platelet-vascular wall interactions.
    Moncada S.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 Sep 23; 15():507-12. PubMed ID: 2936156
    [No Abstract] [Full Text] [Related]

  • 15. [Inhibition of metastasis by anti-platelet agents-prostaglandins].
    Niitsu Y, Urushizaki I.
    Gan To Kagaku Ryoho; 1985 Jun 23; 12(6):1228-34. PubMed ID: 3890759
    [Abstract] [Full Text] [Related]

  • 16. Potential role of platelets and coagulation factors in the metastasis of prostatic cancer.
    Bhatti RA, Gadarowski J, Ray P.
    Invasion Metastasis; 1996 Jun 23; 16(2):49-55. PubMed ID: 9030239
    [Abstract] [Full Text] [Related]

  • 17. Thromboxane synthetase inhibition results in increased platelet sensitivity to prostacyclin.
    Bertelé V, Falanga A, Roncaglioni MC, Cerletti C, de Gaetano G.
    Thromb Haemost; 1982 Jun 28; 47(3):294. PubMed ID: 7051411
    [No Abstract] [Full Text] [Related]

  • 18. Animal models for the study of platelet-tumor cell interactions.
    Donati MB, Rotillio D, Delaini F, Giavazzi R, Mantovani A, Poggi A.
    Prog Clin Biol Res; 1982 Jun 28; 89():159-76. PubMed ID: 7202205
    [No Abstract] [Full Text] [Related]

  • 19. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W, Roth P, Weber PC.
    Thromb Haemost; 1981 Jun 30; 45(3):204-7. PubMed ID: 7025338
    [Abstract] [Full Text] [Related]

  • 20. Analysis of the biological activity of azoprostanoids in human platelets.
    Gorman RR, Shebuski RJ, Aiken JW, Bundy GL.
    Fed Proc; 1981 May 15; 40(7):1997-2000. PubMed ID: 7014259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.